ClinicalTrials.Veeva

Menu

Project OASIS: Optimizing Approaches to Select Implementation Strategies

VA Office of Research and Development logo

VA Office of Research and Development

Status

Invitation-only

Conditions

Cirrhosis
Hepatocellular Carcinoma

Treatments

Behavioral: OASIS DA training
Behavioral: Current DA Tool training

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT06061328
IIR 22-033
1I01HX003610-01A2 (Other Identifier)

Details and patient eligibility

About

Barriers that prevent healthcare methods supported by science from being adopted in the real world have led to low-quality, inequitable medical care. Implementation science aims to bridge the evidence-to-practice gap but still lacks simple and convenient methods to identify implementation barriers, systematically track which strategies work to improve care, and provide accessible data and expert recommendations to guide implementation strategy selection for use in research and practice. Project OASIS (Optimizing Approaches to Select Implementation Strategies) will conduct a hybrid type-III, cluster-randomized trial of a new decision aid tool that matches site variables and barriers to successful implementation strategies.

Full description

Implementation science aims to improve the uptake of evidence-based health care practices (EBPs) by defining barriers that prevent their use, offering strategies to overcome these barriers, and developing methods that help clinicians and researchers choose strategies that best address the barriers they encounter. With strategy selection often being inefficient and idiosyncratic, experts have called for methods to make strategy selection scientific, data-driven, and "precise." This "precision implementation" causes a critical need to identify implementation barriers and facilitators quickly and uniformly, track implementation strategy use and effectiveness, and incorporate data and expert knowledge into the process of matching strategies to barriers. Without these improvements, there is a risk of perpetuating implementation failures and health care disparities.

Project OASIS (Optimizing Approaches to Select Implementation Strategies) will conduct a cluster-randomized, hybrid type III trial to compare a machine learning derived decision aid (DA) for selecting implementation strategies with a current expert opinion-based tool in 20 VA medical centers. The investigators will apply the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) evaluative framework and assess rates of hepatocellular carcinoma screening (an EBP) for Veterans with cirrhosis at these sites. As this is a facility-level intervention, Veterans with cirrhosis will be cluster randomized to the DA vs. Current Tool arms. The investigators anticipate that Veterans at sites in the DA arm will be significantly more likely to receive screening than Veterans at sites in the Current Tool arm.

Enrollment

8,020 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Veterans:

  • Veterans with two outpatient or one inpatient codes for cirrhosis or its complications who had an encounter in the prior 18 months at a participating VA medical center

VA clinicians:

  • Physicians, advance practice providers, nurses, leadership, and staff engaged with selecting and applying implementation strategies to improve care at a participating VA medical center

Exclusion criteria

  • Veterans post-transplant or with active hepatocellular carcinoma

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

8,020 participants in 2 patient groups

OASIS DA
Experimental group
Description:
Half of the sites will be randomized to receive training on the OASIS decision aid.
Treatment:
Behavioral: OASIS DA training
Current DA Tool
Active Comparator group
Description:
Half of the sites will be randomized to receive training on the current decision aid tool.
Treatment:
Behavioral: Current DA Tool training

Trial contacts and locations

1

Loading...

Central trial contact

Shari S Rogal, MD MPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems